Thrombosis Research
Volume 126, Issue 1 , Pages 32-34 , July 2010

A Computerized Prompt for Thromboprophylaxis in Hospitalized Cancer Patients

  • Grace D. Candelario

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • ,
  • Charles W. Francis

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • James P. Wilmot Cancer Center, University of Rochester, Rochester, N.Y., USA
    • ,
  • Robert Panzer

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • ,
  • Kelly S. McAdam

      Affiliations

    • Southern California Permanente Medical Group, El Cajon, CA, USA
    • ,
  • Diane Cockrell

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • ,
  • Tracy Baird

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • ,
  • Alok A. Khorana

      Affiliations

    • Department of Medicine, University of Rochester, Rochester, N.Y., USA
    • James P. Wilmot Cancer Center, University of Rochester, Rochester, N.Y., USA
    • Corresponding Author InformationCorresponding author. 601 Elmwood Ave, Box 704, Rochester, NY 14642. Tel.: +1 585 275 4797; fax: +1 585 273 1042.

Received 29 July 2009 ,Revised 24 September 2009 ,Accepted 24 September 2009.

References 

  1. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119:60–68
  2. Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:2339–2346
  3. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632–634
  4. Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–1850
  5. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166:458–464
  6. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol. 2006;24:484–490
  7. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484–3488
  8. Elting LS, Escalante CP, Cooksley C, et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004;164:1653–1661
  9. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800
  10. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874–879
  11. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332:325–329
  12. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S–453S
  13. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. J Clin Oncol. 2007;25(34):5490–5505
  14. Wagman LD, Baird MF, Bennett CL, et al. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006;4:838–869
  15. Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica. 2002;87:746–750discussion 250
  16. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387–394
  17. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119:145–155
  18. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg. 2005;241:397–415
  19. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969–977
  20. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936–945
  21. Stinnett JM, Pendleton R, Skordos L, et al. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol. 2005;78:167–172

PII: S0049-3848(09)00415-0

doi: 10.1016/j.thromres.2009.09.022

Thrombosis Research
Volume 126, Issue 1 , Pages 32-34 , July 2010

Article Tools

* Image Usage & Resolution